# CF Bankshares Inc.: Form 10-Q for the period ended Jun 30, 2024

- Company: [CF Bankshares Inc.](/companies/cfbk.md) (CIK 1070680)
- Form: 10-Q
- Filed: 2024-08-14
- Accepted by EDGAR: Aug 14, 2024, 13:16 ET
- Period: 2024-06-30
- Accession: 0001070680-24-000027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070680/000107068024000027/cfbk-20240630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070680/000107068024000027/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 3 months, 2024-04-01 to 2024-06-30 | $237.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2024-01-01 to 2024-06-30 | $932.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-04-01 to 2024-06-30 | $1.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-01-01 to 2024-06-30 | $4.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-04-01 to 2024-06-30 | $0.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-01-01 to 2024-06-30 | $0.74 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-04-01 to 2024-06-30 | $0.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-01-01 to 2024-06-30 | $0.74 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-04-01 to 2024-06-30 | 6,256,457 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-01-01 to 2024-06-30 | 6,306,878 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-01-01 to 2024-06-30 | $2.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2024-01-01 to 2024-06-30 | $11.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2024-01-01 to 2024-06-30 | $773.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2024-06-30 | $241.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2024-06-30 | $2.04bn | us-gaap:Assets |
| Total liabilities | at 2024-06-30 | $1.88bn | us-gaap:Liabilities |
| Shareholders' equity | at 2024-06-30 | $159.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,109 characters.

(a) None.

(b) Not applicable.

(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Exchange Act, during the three months ended June 30, 2024.

| Period | Total number of common shares purchased |  | Average price paid per common share | Total number of common shares purchased as part of publicly announced plans or programs (3) | Maximum number of common shares that may yet be purchased under the plans or programs |
| --- | ---: | ---: | ---: | ---: | ---: |
| April 1, 2024 through April 30, 2024 | 2,245 | (1) | 19.56 | 2,245 | 229,402 |
| May 1, 2024 through May 31, 2024 | - |  | - | - | 229,402 |
| June 1, 2024 through June 30, 2024 | - |  | - | - | - |
| Total | 2,245 |  | $19.56 | 2,245 |  |

(1) On July 5, 2023, the Company’s Board of Directors authorized a new stock repurchase program pursuant to which the Company was authorized to repurchase up to 250,000 shares of the Company’s common stock on or before June 30, 2024.

## Risk factors

As filed, 459 characters.

There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors is included in “Item 1A. Risk Factors” of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There were no material changes to those risk factors as presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Filed Aug 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001070680-24-000027. Last ingested by Listed: Nov 13, 2026, 01:50 ET. No prices; not investment advice.
